Meredith Goldwasser

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Meredith Goldwasser:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. SVP, Strategy & Corporate Ops. Stock Option (right to buy) 90,500 27 Feb 2025 Direct

Insider Reports Filed by Meredith Goldwasser

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 27 Feb 2025 1 $0 4 SVP, Strategy & Corporate Ops. 03 Mar 2025, 20:16
PRME Prime Medicine, Inc. 21 Feb 2024 1 $0 4 SVP, Strategy & Corporate Ops. 23 Feb 2024, 17:02
PRME Prime Medicine, Inc. 18 Apr 2023 1 $0 4 SVP, Strategy & Corporate Ops. 20 Apr 2023, 16:25
PRME Prime Medicine, Inc. 31 Mar 2023 1 $0 4 SVP, Strategy & Corporate Ops. 04 Apr 2023, 20:23
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 SVP, Strategy & Corporate Ops. 19 Oct 2022, 20:06